NCT07469306 2026-03-13
Short-Course RT Plus CAPOX and Tislelizumab vs Long-Course CRT Plus Tislelizumab for Locally Advanced Rectal Cancer
Fujian Cancer Hospital
Phase 2 Not yet recruiting
Clinical Trials
38 trialsNCT07464769 2026-03-11
KompXX
Region Jönköping County
Phase NA Not yet recruiting
NCT07191418 2026-03-06
Spearmint
Region Västerbotten
Phase NA Not yet recruiting
NCT07332221 2026-01-12
Application of Toripalimab as Adjuvant Therapy After Esophageal Cancer Surgery: A Multicenter Clinical Trial
Henan Cancer Hospital
Phase 3 Not yet recruiting
NCT07333287 2026-01-12
A Multicenter Single-arm Prospective Clinical Study on First-line Treatment of Pancreatic Cancer Liver Metastases With Arterial Infusion Chemotherapy and Embolization Combined With Dual Immune Checkpoint Inhibitors.
Shandong Provincial Hospital
Phase 2 Not yet recruiting
NCT07310836 2025-12-30
A Retrospective Study of Safety and Efficacy of Locoregional Therapies Combined With Anti-VEGF/TKIs and Immune Checkpoint Inhibitors for All Comers of Intention-to-treat Patients With Hepatocellular Carcinoma Beyond UCSF Criteria Before Liver Transplantation
Ningbo Medical Center Lihuili Hospital
Not yet recruiting
NCT07306481 2025-12-29
The Efficacy of Preoperative Oral Administration of Lactobacillus Reuteri Combined With Preoperative Neoadjuvant/Conversion Immunotherapy in Patients With Primary Resectable Liver Cancer
Fujian Cancer Hospital
Phase NA Not yet recruiting
NCT07295002 2025-12-19
Co-SNARE
Region Stockholm
Phase NA Not yet recruiting
NCT07203690 2025-10-02
Development and Application of AI-Based Therapeutic Strategies for Esophageal Cancer Integrating Multimodal Imaging and Digital Pathology
Henan Cancer Hospital
Not yet recruiting
NCT07128251 2025-08-17
A Single-Arm, Multicenter, Exploratory Clinical Study of Transarterial Chemoembolization (TACE) Combined With Iparomlimab and Tuvonralimab Injection and Bevacizumab Injection for the Treatment of Unresectable, Non-Metastatic Hepatocellular Carcinoma (HCC)
Anhui Provincial Hospital
Phase 2 Not yet recruiting
NCT07119957 2025-08-13
ProspEXPO
University Hospital, Angers
Phase NA Not yet recruiting
NCT07046221 2025-07-20
Tislelizumab Combined With Chemotherapy for Resectable Esophageal Squamous Cell Carcinoma Followed by CRT or Surgery
Fujian Cancer Hospital
Phase 2 Not yet recruiting
NCT07070713 2025-07-17
Efficacy and Safety of FOLFOX+Cetuximab vs. FOLFOXIRI+Bevacizumab Both With QL1706 in First-Line Treatment of Left-Sided mCRC
Fujian Cancer Hospital
Phase 2 Not yet recruiting
NCT06971848 2025-07-11
ETCABIO
University Hospital, Angers
Phase NA Not yet recruiting
NCT07041515 2025-06-27
Knowledge-enhanced Digital Intervention to Prevent Low Anterior Resection Syndrome
National Cancer Center, Korea
Phase NA Not yet recruiting
NCT07034118 2025-06-24
Definitive Proton Radiotherapy Combined With Chemotherapy and Immunotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma: A Phase I Clinical Study
Anhui Provincial Hospital
Phase 1 Not yet recruiting
NCT06982664 2025-05-21
Effect of Preserving the Left Colic Artery on Proximal Bowel Perfusion
Ningbo Medical Center Lihuili Hospital
Phase NA Not yet recruiting
NCT06979986 2025-05-20
SLND Versus Non-Dissection Following ESD for T1a Stage Esophageal Squamous Cell Carcinoma
Fujian Cancer Hospital
Phase NA Not yet recruiting
NCT06692270 2025-02-28
Tislelizumab as Single-Agent Neoadjuvant Immunotherapy in Resectable Esophageal Squamous Cell Carcinoma
Fujian Cancer Hospital
Phase 2 Not yet recruiting
NCT06833775 2025-02-20
Evaluation of Neoadjuvant Therapy Efficacy and Postoperative Pathological Indicators in Esophageal Cancer Using CT and Multimodal MRI
Henan Cancer Hospital
Not yet recruiting
NCT06818214 2025-02-10
Mechanistic Study on the Diagnosis of Esophageal Cancer Lymph Node Metastasis Using Spectral CT, Multimodal MRI, FAPI PET-CT, Pathology, and AI Evaluation System
Henan Cancer Hospital
Not yet recruiting
NCT06760676 2025-01-07
A Multiple Tumor Species, Open and Multi-center Clinical Study of Alpaloritovorelli Antibodies (QL-1706) Combined with Pulsed Low Dose Rate External Irradiation (PLDR) for Disease Progression After Previous Anti-tumor Therapy
Anhui Provincial Hospital
Phase 1 Not yet recruiting
NCT06654947 2024-12-16
A Single-arm, Open-label, Prospective Clinical Study of Surufatinib Combined With Immunotherapy and Chemotherapy for Unresectable or Metastatic Biliary Tract Cancer.
Fujian Cancer Hospital
Phase 2 Not yet recruiting
NCT06685354 2024-11-12
Sequential T and I With H101 Via HAI for BCLC C Stage HCC: A Prospective Single-Center Single-Arm Pilot Study
Henan Cancer Hospital
Phase 2 Not yet recruiting
NCT05628610 2024-08-13
Tislelizumab Combined With Chemotherapy or Radiotherapy in the Treatment of Advanced or Recurrent Metastatic Elderly Esophageal Cancer
Fujian Cancer Hospital
Phase 2 Not yet recruiting
NCT06490913 2024-07-08
Chemotherapy Plus EGFR Monoclonal Antibody in Patients With Liver Metastases From Colorectal Cancer With ctDNA Superselective Negative Genes
Fujian Cancer Hospital
Phase 2 Not yet recruiting
NCT06468644 2024-06-21
Phase II Study of Different Doses of Radiotherapy Combined With Sintilimab in the Treatment of Locally Advanced Esophageal Squamous Cell Carcinoma
Fujian Cancer Hospital
Phase 2 Not yet recruiting
NCT06468670 2024-06-21
Short-course Radiotherapy Combined With Sintilimab for Neoadjuvant Treatment of Esophageal Squamous Cell Carcinoma
Fujian Cancer Hospital
Phase 2 Not yet recruiting
NCT06469671 2024-06-21
ArtInCol
State Scientific Centre of Coloproctology, Russian Federation
Phase NA Not yet recruiting
NCT06218888 2024-01-23
A Phase II Clinical Study of the Efficacy and Safety of Tislelizumab Combined With Fruquintinib and Chidamide in the Treatment of Unresectable or Advanced Microsatellite Stabilized (MSS/pMMR) Colorectal Cancer With Liver Metastases
Fujian Cancer Hospital
Phase 2 Not yet recruiting
NCT06053996 2023-09-26
TROS-8
Sheba Medical Center
Phase NA Not yet recruiting
NCT05978882 2023-08-07
Feasibility Study of Sentinel Navigation Surgery in Early Gastric Cancer Using Fluorescence (SENORITA4)
National Cancer Center, Korea
Phase NA Not yet recruiting
NCT05922358 2023-06-28
Phase II Study of Reuse of Oxaliplatin Hypersensitivity in Gastrointestinal Tumors
Fujian Cancer Hospital
Phase 2 Not yet recruiting
NCT05897138 2023-06-13
A Study to Evaluate Lenvatinib Plus Tislelizumab for Locally Advanced Unresectable or Metastatic Hepatocellular Carcinoma With Hepatitis B Virus Infection and Biomarker Analyses
Fujian Cancer Hospital
Phase 2 Not yet recruiting
NCT05887505 2023-06-06
Effects of Vitamin D Status and Multiple Mega-dose Supplementation on Health Care Disparities in Perioperative Patients With Hepatocellular Carcinoma Receiving Hepatectomy
Taoyuan General Hospital
Phase NA Not yet recruiting
NCT05640726 2022-12-07
The First-line Treatment of RCLM With RAS Mutation Was Local Short-course Radiotherapy (SCRT) + PD-1+ Standard Therapy
Fujian Cancer Hospital
Phase 2 Not yet recruiting
NCT04634448 2020-11-18
PeriAPPAC-T
Turku University Hospital
Phase NA Not yet recruiting
NCT02497820 2016-08-25
CaPP3 Israel
Tel-Aviv Sourasky Medical Center
Phase 3 Not yet recruiting